StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Rakesh Bansal

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byRakesh BansalHorizon: NA (inferred Swing (≤2wk))22 Sept 2026via CNBC Awaaz.

Entry₹1,170.9Inferred
Target₹1,200
Total upside +2.49% (call closed)
Stop loss₹1,150-1.78% risk
Exit₹1,20025 Sept 2026, 11:05 am
Target hit+2.49%0.00%upside left
Follow Rakesh Bansal for new calls(31% target hit, 269 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 204 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Sept 2026
4 supporting1 neutral0 opposing
Supports the BUY call (4)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·25 Sept · today

Bernstein bets on this drugmaker for 28% upside citing a key value driver for the future

NewsCnbc-Tv18·18 Sept · 6d ago

(opens in new tab)

India's Pharma Market Expands 10.7% On GLP-1 Launch: Zydus, Glenmark Lead Large-Cap Growth

NewsNdtv-Profit·9 Sept · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·12 Aug · 1mo ago

Neutral / worth noting (1)

Zydus Lifesciences (NSE:ZYDUSLIFE): Why Did It Publish a Lost Share Certificate Notice?

NewsGoogle News·24 Sept · today

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Rakesh Bansal

Every call and its outcome